Merck Charged With Hiding Crippling Side Effects of Highly Profitable Cancer Vax

Robert F. Kennedy Jr., who is facing an uphill confirmation battle in the Senate as Donald Trump’s secretary of, has vowed to reign in drug companies, which he’s previously dubbed a “criminal enterprise,” and to demand compensation for people injured by their products.
The US’s number 2 drugmaker is facing a jury trial after being charged with marketing its Gardasil cancer vaccine as safe in spite of evidence to the contrary.
The drug has been heavily prescribed and marketed to people ages 9-45 in the US, the EU and Australia, and deployed in developing countries via grants from Gavi, the Vaccine Alliance, for the prevention of cervical, head, neck and other cancers caused by HPV, netting Merck a cool $8+ bln in profits 2023.

However, critics including RFK Jr. have called Gardasil “dangerous and defective” and said it could actually increase the risk of some cancers, and cause an array of life-altering injuries, from extreme migraines and memory problems to episodic paralysis, heart issues, hyperinsomnia and gastroparesis, leaving some teens, the drug’s main target demographic, essentially crippled.

Lawyers representing a Los Angeles woman accuse the company of misleading consumers by overstating Gardasil’s benefits, and covering up side effects.
Merck’s lawyers promise to “vigorously defen[d] against these claims” and say that there’s no proof her injuries were “actually caused” by the jab.
Merck has paid out billions of dollars in damages over the years, including a $4.85 billion settlement to victims of Vioxx, an anti-inflammatory drug found to cause heart attacks and strokes among thousands of Americans, in 2007.
It’s also been accused of criminal activities abroad, with Russia’s Radiological, Chemical and Biological Defense Forces releasing thousands of documents seized in Ukraine revealing that Merck and other US and European drug companies actively tested their products on unwitting Ukrainians.

RFK Jr. vs. Big Pharma Goliath: What Can Be Done to Rein in Drug Makers, Big Food and the FDA

Donald Trump has tapped Robert F. Kennedy Jr. for HHS chief – the top advisor to the president on health-related matters, and chief administrator overseeing the Food and Drug Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, Medicare and Medicaid. Here’s what he can actually do to make real change.
Fixing even a fraction of the problems contributing to America’s health crisis could prove daunting, with the nation facing an obesity epidemic (over 70% of American adults are obese or overweight), an addiction scourge (15% use illicit drugs, 20% suffer from alcohol dependency), a prescription drug crisis (66% use at least one prescription medication), contaminated drinking water (a concern for nearly half of the population), skyrocketing autism (which affects one in 36 children, compared to about one per 1,000 in the 1980s), and other serious health-related issues.
Kennedy has recognized the gargantuan scope of the challenge, saying in a recent interview that the US health care system as it’s presently set up means there’s “nothing more profitable” than keeping Americans sick “for life,” with chronic disease a big business he estimates to be worth some $4.3 trln (i.e. about five times the size of the US’s 2024 defense budget).
Kennedy has yet to lay out the details of his agenda as potential Trump Health and Human Services Secretary, including to make good on promises to rein in Big Pharma, but has dropped important hints in recent interviews and speeches about:

negotiating with drug companies on medication costs,

barring major pharmaceuticals from being able to spend billions of dollars on television advertising, which he has characterized as a disguised form of lobbying and insurance against media criticism,

ending vaccine mandates, at least for federal agencies and the military, and lobbying to do so at the state level, while preserving Americans’ rights to make an informed choice,

reforming vaccine research standards. Kennedy has been outspoken in his criticism of former chief presidential medical advisor Anthony Fauci and others at the NIH over US-funded gain of function research thought to have ultimately caused the Covid crisis.

As Secretary of Health and Human Services, Kennedy would also be responsible for America’s food safety regulations, an area of government he has said repeatedly has been captured by big corporations. On this front, Kennedy could:

encourage municipalities to get rid of fluoride in tap water, citing fluoride’s long-suspected impact IQ levels in children,

push to ban or at least restrict artificial food coloring, additives and chemicals,

restrict processed foods in school lunches, and roll back subsidies for corn and soy,

end perceive FDA overregulation on “stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals and anything else that advances human health and can’t be patented by Pharma,” as he suggested in a recent X post.

RFK Jr. also wants federally-funded medical schools to focus more on nutrition, and to create a national fitness standard like the one promoted by his uncle – President John F. Kennedy.

Kennedy has promised to take on conflicts of interest between regulators and the entities they’re meant to be regulating – citing money given to the FDA by Big Pharma, and corporate links to health and dietary advisories.

The HSS Secretary job requires Senate approval, meaning Kennedy’s selection could become a daunting uphill battle come January, especially if Big Pharma and Big Food use their lobbying muscle to pull strings to block his appointment.

Battle lines are already being drawn, with GOP senators promising to give him a shot, calling his selection “a bad day for Big Pharma,” and his candidacy a “brilliant” move by Donald Trump. Senate Democrats have rushed to dub Kennedy a “fringe conspiracy theorist” spouting “outlandish views on basic scientific facts,” over his much-publicized vaccine hesitancy, and argued that his selection “would be nothing short of a disaster.”
Senior officials from agencies Kennedy would be tasked with overseeing also called him out, with Clinton-era HHS chief Donna Shalala saying he’s “totally unqualified” and “dangerous” to America and the world.
Former Obama HHS chief Kathleen Sebilius, meanwhile, has expressed hopes that Kennedy would get bogged down in the agency’s bureaucracy. “He has no organizational management experience, and HHS is one of the largest domestic organizations,” she said, highlighting the agency’s 83,000 employee workforce and massive $1.7 trillion budget.
Kennedy has expressed readiness to work with the HHS and its subordinate agencies, but warned naysayers in top jobs, including at the FDA, that he will not tolerate efforts to block his initiatives. “If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags,” he wrote in a tweet last month.

 Fact-Check: Is Trump’s White House Chief of Staff a Big Pharma Lobbyist?

GOP strategist Susi Wiles, who was tapped by President-elect Donald Trump for the position of White House chief of staff, came under criticism on X for being “a Big Pharma lobbyist” promoting Bill Gates’ Gavi, Gilead, and Pfizer, to name just a few. For MAGA Republicans, who largely opposed mandatory COVID vaccinations, it’s a serious matter.
Roger Stone, a long-time Trump ally and Republican political operative, rushed to shred the claims on X: “Susan Wiles has never worked for or represented any pharmaceutical company.”
Do the accusations have merit?

Susan Wiles, nicknamed by Trump “The Ice Maiden”, most recently worked as a co-chair in lobbying firm Mercury‘s Florida and Washington DC offices since February 2022.

On its website Mercury lists GaviFord FoundationTeslaPfizerUnited Nations FoundationKaiser Permanente, and Gilead as being amongst its 550 clients.

While employed by Mercury, Wiles lobbied on behalf of Swisher International, Inc according to US Senate Lobbying Disclosure website. Swisher is an American international tobacco company, listed in disclosure forms as SI Group Client Services.

Wiles lobbying efforts concerned Food and Drug Administration regulations in the US Senate and House of Representatives. However, she was promoting not drugs, but tobacco.

US investigative website Sludge claims Wiles’ tobacco contracts contradicted Trump’s Make American Healthy Again agenda.

Prior to working for Mercury, she had been employed by lobbying company Ballard Partners.
According to lobbying disclosure reports, her clients were:

fossil fuel company Alliance Resource Partners

clean energy advocate Citizens for Responsible Energy Solutions

automobile company General Motors

insurance company Bankers Financial Corporation

international network Children’s Hospital Association, and others.

Still, there are no Big Pharma companies or their subsidiaries in the list of her lobbying efforts between 2017 and now.

Big Pharma Docs: Western Elite Used Ukraine as ‘Guinea Pig for Human Testing’ After 2014 Coup

When conducting human tests, Big Pharma did not think twice before using hospitals in certain developing countries, which don’t have “rigorous controls” for such actions, William Jones, a former White House correspondent and a non-resident fellow of the Chongyang Institute for Financial Studies, told Sputnik.
Sputnik has obtained a trove of documents indicating that rheumatological drugs had been allegedly tested for several years on psychiatric patients of a hospital in the city of Mariupol at the request of major Western pharmaceutical corporations and with the assistance of Ukrainian officials.

The documents contain information pertaining to such companies as Pfizer, AstraZeneca, Celltrion, Novatris International AG, Merck KGaA, and a branch of Samsung that produces medical equipment. The tests were carried out while the Kiev regime held Mariupol until May 2022, when Russia took over the city.

Patients of the Mariupol hospital’s psychiatric ward were most likely used as vulnerable “guinea pigs” in experiments that would not have been permitted in the countries where these pharmaceutical firms are located, William Jones, a former White House correspondent for Executive Intelligence Review and a non-resident fellow of the Chongyang Institute for Financial Studies, Renmin University of China, told Sputnik.
“It has generally been a practice to use some of the developing countries which don’t have such rigorous controls for these types of experiments,” Jones noted, hinting at Ukraine.

After the 2014 Maidan coup in Kiev, the country “effectively became a ‘guinea pig’ for whatever experiments the forces of the Western elites had in store for them, as we see most dramatically in the way in which the ‘nation’ of Ukraine is being whittled down to nothing for the sake of NATO’s surrogate war against Russia,” according to the expert.

He also touched upon the issue of “the extensive network of biological labs that have been set up in Ukraine over the twenty years, largely with the help, and no doubt at the behest, of the United States,” something that Jones recalled had repeatedly been pointed out by Lieutenant General Igor Kirillov, the head of the biological and chemical warfare department of the Russian Defense Ministry.
“Given the present situation in Ukraine with the growing understanding that Ukraine – or NATO – cannot ‘win’ this conflict using conventional weapons, as well as the determination of NATO not to accept a peaceful resolution unless Russia is soundly defeated, it could well lead to the utilization of some form of biological warfare on the part of NATO to ‘even the playing field’,” Jones warned.
In the spring of 2022, Russia’s Radiological, Chemical, and Biological Defense Troops brought to light the alarming scope of US military-biological activities taking place at numerous locations in Ukraine. These investigations revealed the collaboration between Washington and Kiev in researching and handling various highly dangerous pathogens. Subsequently, several of these findings have been independently corroborated.
Back to top button